Navigation Links
Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
Date:12/18/2007

of 129 patients.

About Symphony Allegro

In December 2006, Alexza entered into a collaboration with Symphony Capital LLC, a biotech-focused private equity firm. Under the terms of the agreement, Alexza and Symphony Capital established Symphony Allegro, Inc., which is providing funding to Alexza to accelerate clinical and other related development activities of Staccato alprazolam (AZ-002) and Staccato loxapine (AZ-004 and AZ-104). Alexza has granted a license to the intellectual property for the selected product candidates. Through a purchase option, Alexza retains the exclusive right, but not the obligation, to acquire 100% of the equity of Symphony Allegro at specified prices during the term of the agreement. If Alexza chooses not to exercise the purchase option, Symphony Allegro retains the rights to the product candidates. The term of the agreement is up to four years.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. The Company has six product candidates in development; AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic and bipolar disorder patients, AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches, AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder, AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches, AZ-003 (Staccato fentanyl) for the treatment of
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Calif. , April 30, 2015  IRIDEX Corporation ... release its first quarter 2015 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, May ... quarter and other business developments. Interested parties ...
(Date:4/30/2015)...  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) announced ... results after the market closes on Thursday, May 7, ... be held on Thursday, May 7, 2015, at 4:30 ... To participate in the call, please dial 877-303-1298 (for ... of the teleconference will be available for one week ...
(Date:4/30/2015)... Company plc (NYSE: PRGO ; TASE) today announced that Perrigo ... at the 2015 Deutsche Bank 40 th Annual Healthcare Conference ... Hotel in Boston , MA.  ... Joseph C. Papa will present at the Bank of America ... 12, 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
(Date:5/3/2015)... BolehVPN ” was featured on NewsWatch as part of its ... products available to consumers. Scott Steinberg, a technology expert and ... viewers how to protect their private information. , A lot ... even more so online. It helps everyone stay connected with ... In terms of work, the internet makes things more efficient. ...
(Date:5/3/2015)... MA (PRWEB) May 03, 2015 It is not ... Annual Brain Aneurysm Walk in Memory of Lissa Anne Been ... Lissa organized this great family-friendly event to honor her loving memory. ... its inception. , Just having turned 37, Lissa suffered a ... passed away on August 24, 2012. This event is designed to ...
(Date:5/2/2015)... BC (PRWEB) May 02, 2015 Vancouver fencing ... will now provide valuable advice to prospective clients related to ... are looking to install railings around their decks and patios. ... several questions that pop up once the person rolls up ... phases of installing a railing in finding a gate that ...
(Date:5/2/2015)... 2015 We are pleased to announce ... Center as one of the Top Workplaces of 2015. ... addiction treatment field for their ethics and standards of ... to continue their educational efforts. The Delray Recovery Center ... forgetting their purpose – to help individuals heal from ...
(Date:5/2/2015)... TX (PRWEB) May 02, 2015 ... skin laxity issues of the face, neck and ... new concept with real potential for the success ... by the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s ... FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature controlled ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
... , THURSDAY, March 15 (HealthDay News) -- Eating ... in fried foods, baked goods and other prepared meals and ... -- behavior, new research suggests. In conducting the study, ... Medicine analyzed the diet and behavior of 945 men and ...
... DENVER Patients with early stage malignant pleural mesothelioma ... the lungs, may be eligible for aggressive multi-modality therapy ... approaches, and controversy has existed about which approach is ... extensive surgery where surgeons remove the entire diseased lung, ...
... in the gym, surrounded by others, pounding to the beat in ... when it comes to the experience of changing in the locker ... front of others, can be very discomfiting. It,s a complex experience ... than in any other space. "I walk into the change ...
... alcohol consumption has been consistently associated with lower risk ... certain, especially among women. A total of 83,578 ... free of diagnosed cardiovascular disease and cancer at baseline ... alcohol consumption were assessed at baseline and updated approximately ...
... there is a clear relationship between androgenetic alopecia (common ... enlargement of the prostate that appears in aging men ... condition appears in 50% of men over 60 year ... In the light of the study published in the ...
... A 21,626-person study published today in the Journal ... rate for children and adolescents with acute lymphoblastic leukemia ... percent in those diagnosed during the years 1990-1994, to ... "The improved survival is due to using existing ...
Cached Medicine News:Health News:Could Trans Fats Make You Cranky? 2Health News:Pleurectomy/decortication proposed preferred surgical procedure 2Health News:The stress of undress 2Health News:The stress of undress 3Health News:Moderate drinking associated with lower risk of stroke in women 2Health News:A study confirms the correlation between premature alopecia and prostate conditions 2Health News:Largest ever study of childhood ALL shows improving survival 2
... tiny, water-resistant monitor captures the data you ... ,Requiring only five electrodes, the DigiTrak ... the entire patient test, which can be ... AA battery. Three channels of ECG recording ...
... biograph 6 offers the ultimate ... diagnosis and treatment in oncology, ... high-quality PET/CT whole body scans ... Our comprehensive suite of clinical ...
... Lunar DPX Duo is a SmartBeam platform ... get measurements of the two most clinical ... seconds, and at a low radiation dose., ... based on Windows, optimizes productivity and ensures ...
... ScImage's PICOMEnterprise is a web-enabled ... custom reporting and custom workflow integration. ... captures, stores, distributes and archives images, ... any DICOM and many non-DICOM devices ...
Medicine Products: